High Flow Nasal Cannula in Patients With Cancer at the End of Life.
Patricia S BramatiAhsan AzharRida KhanMargarita TovbinAlex CooperImelda PangemananBryan FellmanEduardo Bruera
Published in: Journal of pain and symptom management (2023)
Only a minority of patients with cancer at the end of life can be liberated from HFNC, and only a minority are discharged alive. This information is important when discussing goals of care with patients and their families before initiating HFNC.